HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to the preparation of a compound for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pyrrolidinyl or biphenyl derivatives which are used in a process for preparing the HCV inhibiting compound.

Saved in:
Bibliographic Details
Main Authors Goodrich, Jason, Good, Andrew C, James, Clint A, Lavoie, Rico, Hamann, Lawrence G, Deon, Daniel H, Langley, David R, Wang, Gan, Meanwell, Nicholas A, Nguyen, Van N, Yang, Fukang, Ruediger, Edward H, Belema, Makonen, Lopez, Omar D, Bachand, Carol, St. Laurent, Denis R, Romine, Jeffrey Lee, Snyder, Lawrence B, Martel, Alain
Format Patent
LanguageCroatian
English
Published 19.04.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to the preparation of a compound for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pyrrolidinyl or biphenyl derivatives which are used in a process for preparing the HCV inhibiting compound.
Bibliography:Application Number: HR2016P000410T